Publications
Publications
Show Results For
- All HBS Web
(1,189)
- Faculty Publications (276)
←
Page 14 of 276
Results
- April 1993 (Revised November 1994)
- Case
Chiron Corp.
Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
- March 1991 (Revised July 2001)
- Supplement
Ann Hopkins (B)
By: Joseph L. Badaracco Jr. and Ilyse Barkan
Describes the reasons why the courts found in favor of Ann Hopkins in the sexual discrimination suit. Also explains why the courts concluded she was the victim of sexual stereotyping. View Details
- February 1991 (Revised August 2001)
- Case
Ann Hopkins (A)
By: Joseph L. Badaracco Jr. and Ilyse Barkan
Intended to help students understand the many barriers organizations face as their members and their management ranks grow more diverse. As a case on business ethics, it encourages students to discuss what "fairness" and "diversity" mean when an organization is also... View Details
- June 1984
- Case
Federal Trade Commission and the Shared Monopoly Case against the Ready-to-Eat Cereal Manufacturers
By: Thomas K. McCraw and Richard S. Tedlow
- 1984
- Book
The Results and Interpretation of Three Field Trials of Lysine Fortification of Cereals
By: James E. Austin, Jean Pierre Habicht, Max Milner, Vernon Young and Linda D. Myers
- September 1982 (Revised June 1992)
- Case
Barbara J. Key vs. the Gillette Co. (B)
Keywords: Courts and Trials
- September 1982 (Revised October 1990)
- Case
Barbara J. Key vs. the Gillette Co. (A)
Keywords: Courts and Trials
- Article
On the Optimal Structure of Liability Laws
By: Jerry R. Green
We consider the control of tvo-party accidents through the use of liability rules that assign damages according to whether or not predetermined standards for care have been met. Particular emphasis is given to how the differential in the costs of accident avoidance... View Details
- September 1973 (Revised October 1980)
- Case
Sea Pines Racquet Club
By: W. Earl Sasser
The student is required to develop a strategy for a tennis club of a large resort area. The tennis director must decide how many courts he needs to build within the next three years, what surface they should have, and how much he should charge for their use.... View Details
- Research Summary
Corporate Governance
The characteristics and structure of boards of directors have important implications for firm performance. Professor Wang has found that firms with well-connected boards whose members have strong network connections provide economic benefits that are not immediately... View Details
- Research Summary
Mediation and Alternative Dispute Resolution
Disputes between organizations and among individuals are an all-too-familiar feature of modern life. Lengthy court proceedings consume resources, damage relationships, and often yield outcomes that do not fully satisfy the real needs of the litigants. As a result,... View Details
- Forthcoming
- Article
Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation
By: Amitabh Chandra, Jennifer Kao, Kathleen L. Miller and Ariel Dora Stern
Regulators of new products confront a tradeoff between speeding a product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if regulators can use new policy to... View Details
- Forthcoming
- Article
Sending a Message: An Empirical Assessment of Responses to Punitive and Non-punitive Compliance Messaging Strategies
By: Jodi L. Short, Michael W. Toffel, Elizabeth A. Keenan and Melissa Ouellet
Regulators operate in an increasingly hostile political environment. The U.S. Supreme Court is ramping up efforts to curtail the authority of administrative agencies. The second election of Donald Trump to the presidency has unleashed a torrent of anti-regulatory... View Details
Keywords: Field Experiment; Compliance; Compliance Programs; Compliance Policies; Regulatory Enforcement; Environmental Regulation; Environmental Policy; Government Experimentation; Governance Compliance; Government Administration; Governing Rules, Regulations, and Reforms; Business and Government Relations; Construction Industry; Public Administration Industry; California; United States
- Forthcoming
- Article
Should Human Capital Development Programs Be Voluntary or Mandatory? Evidence from a Field Experiment
By: Jason Sandvik, Richard Saouma, Nathan Seegert and Christopher Stanton
In a field experiment, we find large differences in productivity treatment effects between voluntary and mandatory workplace mentorship programs. A significant portion of this difference is due to the best employees opting into the program when it is voluntary and... View Details
- ←
- 14